ST JUDE MEDICAL $47.28

up +0.56


21/5/2013 09:21 AM  |  NYSE : STJ  |  Industries : Manufacturing / Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
12 Mo. Price Change : 25% - STJ has underperformed the S&P 500 by 4%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. St. Jude's RESPECT Trial for PFO Closure Highlighted at ...

    Benzinga

  2. St. Jude Beats Profit Forecast By Slashing Costs

    Investors Business Daily

  3. St. Jude 4Q Profit Slumps 2% on Soft Pacemaker Sales

    FOXBusiness

  4. Earnings Scheduled For January 23, 2013

    Benzinga

  5. Earnings Expectations for the Week of January 21

    Benzinga

  6. St. Jude Wins CE Mark Approval for ViewFlex Xtra ICE Catheter

    Benzinga

  7. UPDATE: BMO Capital Markets Downgrades St. Jude Medical to Market ...

    Benzinga

  8. Will the ObamaCare Excise Tax Kill the Medical Device Sector?

    Benzinga

  9. Why Cooperman and Price Are Betting on Boston Scientific's Turnaround

    GuruFocus

  10. Surprisingly, Politicians Could Boost Medical Device ETFs

    Benzinga

  11. My Best Healthcare Stock Picks For 2013 | Last Year's Picks Gained ...

    GuruFocus

  12. Tellabs and St. Jude Join List of Companies Issuing Special ...

    Benzinga

  13. Benzinga's Top Upgrades

    Benzinga

  14. Benzinga Market Primer, Friday November 30

    Benzinga

  15. Mid-Morning Market Update: Markets Largely Flat; Hostess to ...

    Benzinga

  16. Stocks Mixed In Early Action; Salesforce.com, Cirrus Logic Gap Up

    Investors Business Daily

  17. Benzinga's Top Pre-Market Losers

    Benzinga

  18. Medtronic Earnings Solid, Guidance Cautious

    Investors Business Daily

  19. Medtronic Earnings Report Comes Amid U.S. Headwinds

    Investors Business Daily

  20. More Pain Awaits Medical Device ETFs

    Benzinga

  21. Weekly CEO Sells Highlight: Entegris, Honeywell International, St ...

    GuruFocus

  22. St Jude Medical, Inc. (STJ) Chairman, CEO & President Daniel J ...

    GuruFocus

  23. My 5 Favorite Health Care Growth Picks of the Next 5 Years

    GuruFocus

  24. Benzinga's Top Downgrades

    Benzinga

  25. A Peek Into The Market Before The Trading Starts

    Benzinga

  26. St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical ...

    Benzinga

  27. Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective ...

    Benzinga

  28. Baxter Q3 Sales Light; Medtech Stocks Fall

    Investors Business Daily

  29. Benzinga's Top Downgrades

    Benzinga

  30. A Peek Into The Market Before The Trading Starts

    Benzinga

  31. Weak Earnings Pull Stocks Lower

    At Market Intelligence Center

  32. Weak Earnings Pull Stocks Lower

    At Market Intelligence Center

  33. St. Jude Falls On Sales Drop, Possible Warning Letter

    Investors Business Daily

  34. Stock Futures Point to Mixed Open on Earnings, Housing Data with ...

    At Market Intelligence Center

  35. Stock Futures Point to Mixed Open on Earnings, Housing Data with ...

    At Market Intelligence Center

  36. Stocks Open Mixed As IBM Drags, Homebuilders Surge

    Investors Business Daily

  37. Earnings Scheduled For October 17, 2012

    Benzinga

  38. Edwards, Other Medical Stocks Dip In Sync With Market

    Investors Business Daily

  39. Six Stocks Will Benefit If Mitt Romeny Wins

    GuruFocus

  40. Six Stocks That Will Benefit If Mitt Romney Wins

    GuruFocus

  41. Medtronic (MDT) Dividend Stock Analysis 2012

    GuruFocus

  42. Benzinga's Top Upgrades

    Benzinga

  43. St Jude Medical (STJ) Sees Over 3x Normal Option Volume with Stock ...

    At Market Intelligence Center

  44. St. Jude Cuts 300 Jobs

    Benzinga

  45. Barclays Maintains St. Jude's PT & Rating

    Benzinga

  46. Health Care Sector Wrap

    FOXBusiness

  47. Stocks Mixed After Data, WalMart Earnings

    At Market Intelligence Center

  48. Health Care Sector Wrap

    FOXBusiness

  49. St. Jude Medical Announces Third Quarter Dividend

    Benzinga

  50. Health Care Sector Wrap

    FOXBusiness

  51. UPDATE: Deutsche Bank Reduces PT to $47 on St. Jude Medical on ...

    Benzinga

  52. Stocks Get Lift from Data, Earnings with Intel (INTC) and Vivus ...

    At Market Intelligence Center

  53. St Jude Medical (STJ) Down 3.9% After Lowering Guidance

    At Market Intelligence Center

  54. Stocks Higher After Initial Dip

    At Market Intelligence Center

  55. UnitedHealth's Q2 Earnings Sign Of Insurers Health

    Investors Business Daily

  56. American Capital Agency, St Jude Medical Among Stocks Down on High ...

    FOXBusiness

  57. St. Jude Medical's 2Q Results: Postgame Scorecard

    FOXBusiness

  58. Earnings Scheduled For July 18

    Benzinga

  59. Medtronic, Snyder's-Lance and Other Stocks Insiders Are Buying

    Benzinga

  60. Stock Futures Point to Lower Open

    At Market Intelligence Center

  61. Morgan Stanley Reiterates Overweight on St. Jude Medical

    Benzinga

  62. Stocks See Broad Rally Despite Europe Banking Worries with Boeing ...

    At Market Intelligence Center

  63. Stocks Higher After Fed Official Comments

    At Market Intelligence Center

  64. Goldman Sachs Believes Sell-off in St. Jude Medical Shares is ...

    Benzinga

  65. FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical ...

    Benzinga

  66. From Earlier: St. Jude Medical Announces European Approval and ...

    Benzinga

  67. UPDATE: Citigroup Reiterates Sell Rating, Lowers PT for St. Jude ...

    Benzinga

  68. UPDATE: Goldman Sachs Upgrades St. Jude Medical; Raises PT

    Benzinga

  69. Stocks Mixed as Bargain Hunters Emerge After Slide

    At Market Intelligence Center

  70. St. Jude Medical Announces Results of SCD-HeFT 10-Year Follow-up ...

    Benzinga

  71. UPDATE: Morgan Stanley Upgrades St. Jude Medical; Establishes PT

    Benzinga

  72. St. Jude Medical Announces FDA Approval of Smaller ICD with ...

    Benzinga

  73. St. Jude Medical Announces FDA Approval of Smaller ICD

    Benzinga

  74. Stocks Post Weekly Decline as Global Economy Slows with JP Morgan ...

    At Market Intelligence Center

  75. Stocks Moving Higher, Still Likely to Finish Day With a Loss

    At Market Intelligence Center

  76. Stock Plummet as Anxiety Grows with General Electric (GE) and St ...

    At Market Intelligence Center

  77. St Jude Medical (STJ) Loses 4.4% after Halting Sales of some ...

    At Market Intelligence Center

  78. Stocks Mixed with LinkedIN (LNKD) and Aetna (AET) on the Move

    At Market Intelligence Center

  79. Kensey Nash

    at IBD

  80. Stocks Post Gains After Fed Statement with JP Morgan (JPM) and ...

    At Market Intelligence Center

  81. Market Update

    at Benzinga

  82. Notable Put Options Activity in St. Jude Medical

    at Benzinga

  83. Top Growth Stocks from John Rogers

    at GuruFocus

  84. UPDATE: Goldman Sachs Raises Target to $40 on St Jude Medical

    at Benzinga

  85. St. Jude's Q4 earnings beat

    at IBD

  86. Goldman Sachs Maintains St. Jude Medical Neutral, $38 PT

    at Benzinga

  87. St. Jude Beats, Climbs, Despite Tepid Guidance

    at IBD

  88. Earnings Expectations for the Week of January 23

    at Benzinga

  89. Bank of America Maintains Buy Rating on St Jude Medical

    at Benzinga

  90. Piper Jaffray Gives Insight to Medical Technology Industry Overview

    at Benzinga

  91. Stocks I Can Buy Much Cheaper Than Halvorsen Did

    at GuruFocus

  92. Jefferies Maintains Hold, $38 PT on St Jude Medical

    at Benzinga

  93. St. Jude Medical Sees Q4 Sales of $1.4B vs $1.4B Est

    at Benzinga

  94. St. Jude Medical Announces Achievement of Stopping Rule and ...

    at Benzinga

  95. Market Gains on Unemployment Data With Amazon (AMZN) and Baidu.com ...

    At Market Intelligence Center

  96. Notable Call Options Activity in St. Jude Medical

    at Benzinga

  97. Piper Jaffray Reiterates Overweight, $52 Target on St Jude Medical

    at Benzinga

  98. Bank of America Reiterates Buy, $43 Target on St Jude Medical

    at Benzinga

  99. Morgan Keegan Maintains Outperform Rating on St. Jude Medical

    at Benzinga

  100. St. Jude Medical downgraded

    at IBD
People viewing STJ also viewed: , , , , , ,
Marketplace
Trading Center